What is the IOL Chemicals And Pharmaceuticals Ltd share price today?

The share price of NSE:IOLCP-EQ on 01 Oct 2026 (as of 15:03:53 IST) is ₹209.04.

What is the NSE:IOLCP-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:IOLCP-EQ 52 week high low range shows a high of ₹219.04 and a low of ₹67.19.

What is the IOL Chemicals And Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, IOL Chemicals And Pharmaceuticals Ltd market cap is ₹60818900000.

What is the shareholding pattern of IOL Chemicals And Pharmaceuticals Ltd Stock?

The shareholding pattern of IOL Chemicals And Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 62.28% Foreign Institutional Investors (FII): 4.87% Domestic Institutional Investors (DII): 0.41% Mutual Funds: 0.02% Retail & Others: 32.42% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of IOL Chemicals And Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of IOL Chemicals And Pharmaceuticals Ltd is 36.178, and the Price-to-Book (PB) ratio is 1.1874, as on 01 Oct 2026.

IOL Chemicals And Pharmaceuticals Share Price

194.69-0.39 (-0.20%)

+98.56% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-0.20%

1 Week

-2.00%

1 Month

-1.42%

3 Month

+31.25%

6 Month

+122.12%

YTD

+136.68%

1 Year

+98.56%

5 Year

+59.96%

10 Year

+665.89%

Max

+1743.66%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

191.00

188.61

143.55

86.92

67.19

High

198.00

204.30

224.00

About

IOL Chemicals & Pharmaceuticals Ltd. was established in 1986 IOL Chemicals & Pharmaceuticals is India's one of the leading generic pharmaceutical company and is significant player in the Organic chemicals Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

DRREDDYNSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

IOLCPNSE

LTP

1W Low

1W High

Market cap (₹)

1758.8-1.2 (-0.07%)

1725.50

1778

4,22,427Cr

9144.5-281.5 (-2.99%)

8937.50

9431.50

2,39,982Cr

4558.9-123.1 (-2.63%)

4550.40

4682

1,75,196Cr

1123-11.4 (-1.00%)

1107.30

1150.90

1,13,790Cr

2060.1-9.1 (-0.44%)

2007.80

2086

1,09,143Cr

1325.1+13.8 (1.05%)

1300.20

1337.50

1,07,746Cr

1233+3.6 (0.29%)

1196.90

1250.70

1,01,894Cr

2275.5-124.5 (-5.19%)

2268.70

2426.80

97,264Cr

1666.9-40 (-2.34%)

1647.10

1715

96,376Cr

1961.6+26.6 (1.37%)

1925.70

1990.90

89,592Cr

194.69-3.97 (-2.00%)

188.61

205.75

5,727Cr

IOL Chemicals And Pharmaceuticals Share Price

194.69-0.39 (-0.20%)

+98.56% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years2%

Last year12%

Compounded Profit Growth

10 years-

5 years-

3 years0%

Last year36%

Stock Price CAGR

10 years23%

5 years10%

3 years28%

1 year99%

Return on Equity

10 years9%

5 years9%

3 years8%

Last year8%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	2%	12%
-	-	0%	36%
23%	10%	28%	99%
9%	9%	8%	8%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

DRREDDY

MANKIND

AUROPHARMA

LUPIN

IOLCP

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,758.8	₹422427 Cr	34.92	12.07	62.82	₹11479 Cr
9,144.5	₹239982 Cr	82.05	34.04	128.41	₹2568 Cr
4,558.9	₹175196 Cr	80.33	16.72	97.06	₹2163 Cr
1,123	₹113790 Cr	25.21	9.42	62.53	₹5040 Cr
2,060.1	₹109143 Cr	99.82	6.8	29.25	₹889 Cr
1,325.1	₹107746 Cr	31.97	9.77	57.87	₹3879 Cr
1,233	₹101894 Cr	31.62	5.32	63.99	₹4196 Cr
2,275.5	₹97264 Cr	47.62	13.75	71.08	₹1913 Cr
1,666.9	₹96376 Cr	25.96	17.95	96.84	₹3505 Cr
1,961.6	₹89592 Cr	16.2	30.95	154.35	₹5333 Cr
194.69	₹5727 Cr	34.07	2.19	8.51	₹138 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
₹756 Cr	₹619 Cr	₹580 Cr	₹568 Cr	₹552 Cr	₹528 Cr	₹523 Cr	₹526 Cr	₹502 Cr	₹504 Cr	₹520 Cr	₹545 Cr	₹563 Cr	₹587 Cr	₹523 Cr	₹541 Cr	₹565 Cr	₹572 Cr
₹8 Cr	₹2 Cr	₹5 Cr	₹7 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹6 Cr	₹7 Cr	₹8 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹9 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹7 Cr
₹764 Cr	₹621 Cr	₹586 Cr	₹574 Cr	₹559 Cr	₹532 Cr	₹527 Cr	₹532 Cr	₹510 Cr	₹511 Cr	₹529 Cr	₹552 Cr	₹570 Cr	₹596 Cr	₹530 Cr	₹546 Cr	₹570 Cr	₹579 Cr
₹674 Cr	₹547 Cr	₹543 Cr	₹530 Cr	₹509 Cr	₹484 Cr	₹495 Cr	₹502 Cr	₹468 Cr	₹471 Cr	₹492 Cr	₹497 Cr	₹505 Cr	₹504 Cr	₹493 Cr	₹521 Cr	₹520 Cr	₹538 Cr
₹112 Cr	₹94 Cr	₹63 Cr	₹64 Cr	₹70 Cr	₹67 Cr	₹51 Cr	₹48 Cr	₹58 Cr	₹57 Cr	₹53 Cr	₹71 Cr	₹80 Cr	₹104 Cr	₹49 Cr	₹37 Cr	₹61 Cr	₹52 Cr
₹4 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹2 Cr
₹87 Cr	₹71 Cr	₹28 Cr	₹40 Cr	₹46 Cr	₹45 Cr	₹28 Cr	₹26 Cr	₹40 Cr	₹37 Cr	₹32 Cr	₹51 Cr	₹61 Cr	₹87 Cr	₹33 Cr	₹22 Cr	₹47 Cr	₹39 Cr
₹64 Cr	₹53 Cr	₹21 Cr	₹30 Cr	₹34 Cr	₹31 Cr	₹21 Cr	₹19 Cr	₹30 Cr	₹28 Cr	₹23 Cr	₹38 Cr	₹46 Cr	₹65 Cr	₹24 Cr	₹16 Cr	₹35 Cr	₹30 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
—	—	—	—	—
₹59 Cr	₹59 Cr	₹59 Cr	₹59 Cr	₹59 Cr
₹1740 Cr	₹1629 Cr	₹1553 Cr	₹1449 Cr	₹1334 Cr
₹1740 Cr	₹1629 Cr	₹1553 Cr	₹1449 Cr	₹1334 Cr
₹1799 Cr	₹1688 Cr	₹1612 Cr	₹1508 Cr	₹1392 Cr
₹85 Cr	₹78 Cr	₹66 Cr	₹56 Cr	₹53 Cr
₹2 Cr	₹0	₹4 L	₹14 L	₹43 L
₹11 Cr	₹7 Cr	₹7 Cr	₹2 Cr	₹3 Cr
₹98 Cr	₹85 Cr	₹73 Cr	₹58 Cr	₹57 Cr
—	—	—	—	—
₹483 Cr	₹428 Cr	₹469 Cr	₹314 Cr	₹409 Cr
₹70 Cr	₹63 Cr	₹55 Cr	₹54 Cr	₹54 Cr
₹132 Cr	₹117 Cr	₹33 Cr	₹80 Cr	₹43 Cr
₹49 Cr	₹31 Cr	₹40 Cr	₹54 Cr	₹69 Cr
₹733 Cr	₹639 Cr	₹597 Cr	₹503 Cr	₹575 Cr
₹2630 Cr	₹2411 Cr	₹2282 Cr	₹2068 Cr	₹2024 Cr
₹6 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹18 L
₹132 Cr	₹117 Cr	₹33 Cr	₹80 Cr	₹43 Cr
—	—	—	—	—
₹1632 Cr	₹1544 Cr	₹1236 Cr	₹995 Cr	₹762 Cr
₹451 Cr	₹374 Cr	₹303 Cr	₹243 Cr	₹201 Cr
₹1182 Cr	₹1171 Cr	₹933 Cr	₹752 Cr	₹561 Cr
₹94 Cr	₹21 Cr	₹100 Cr	₹81 Cr	₹102 Cr
₹17 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹0
₹17 Cr	₹17 Cr	₹17 Cr	₹17 Cr	₹0
₹20 Cr	₹12 Cr	₹24 Cr	₹10 Cr	₹11 Cr
₹45 Cr	₹9 Cr	₹50 Cr	₹233 Cr	₹205 Cr
₹1359 Cr	₹1231 Cr	₹1125 Cr	₹1102 Cr	₹881 Cr
—	—	—	—	—
₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr
₹371 Cr	₹361 Cr	₹425 Cr	₹326 Cr	₹410 Cr
₹603 Cr	₹514 Cr	₹471 Cr	₹505 Cr	₹470 Cr
₹198 Cr	₹208 Cr	₹143 Cr	₹22 Cr	₹140 Cr
₹30 Cr	₹27 Cr	₹25 Cr	₹30 Cr	₹31 Cr
₹65 Cr	₹67 Cr	₹90 Cr	₹82 Cr	₹90 Cr
₹1271 Cr	₹1180 Cr	₹1157 Cr	₹967 Cr	₹1143 Cr
₹537 Cr	₹541 Cr	₹560 Cr	₹464 Cr	₹567 Cr
₹2630 Cr	₹2411 Cr	₹2282 Cr	₹2068 Cr	₹2024 Cr
₹61	₹57	₹274	₹257	₹237
₹61	₹57	₹55	₹257	₹237

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
₹184 Cr	₹138 Cr	₹182 Cr	₹189 Cr	₹225 Cr
₹85 Cr	₹80 Cr	₹60 Cr	₹44 Cr	₹33 Cr
-₹17 Cr	-₹21 Cr	₹90 Cr	-₹64 Cr	-₹102 Cr
₹252 Cr	₹197 Cr	₹332 Cr	₹169 Cr	₹156 Cr
₹214 Cr	₹179 Cr	₹290 Cr	₹122 Cr	₹93 Cr
-₹198 Cr	-₹154 Cr	-₹191 Cr	-₹120 Cr	-₹121 Cr
-₹29 Cr	₹46 Cr	-₹93 Cr	-₹4 Cr	-₹2 Cr
-₹13 Cr	₹70 Cr	₹6 Cr	-₹2 Cr	-₹29 Cr
₹78 Cr	₹8 Cr	₹1 Cr	₹3 Cr	₹32 Cr
₹65 Cr	₹78 Cr	₹8 Cr	₹1 Cr	₹3 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

IOL Chemicals And Pharmaceuticals Share Price

194.69-0.39 (-0.20%)

+98.56% past 1 Year

Shareholding summary

Promoters

62.28%

FII

7.26%

DII

0.01%

0.29%

Others

30.16%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
62.28%	62.28%	57.48%	52.62%	52.62%	52.62%
7.26%	4.87%	1.72%	2.08%	2.25%	2.59%
0.01%	0.41%	0.00%	0.00%	0.02%	0.00%
0.29%	0.02%	0.02%	0.02%	0.02%	0.02%
30.16%	32.42%	40.78%	45.28%	45.09%	44.77%

Bulk & block deals

Name

Microcurves Trading Private Limited

Hrti Private Limited

Microcurves Trading Private Limited

Qe Securities Llp

Hrti Private Limited

Qe Securities Llp

Polunin Emerging Markets Small Cap Fund Llc

Junomoneta Finsol Private Limited

Qe Securities Llp

Graviton Research Capital Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
08 Jul 2026	Sell	26.92 Cr	₹171.04	15.74 L	Bulk	0.536278	NSE
08 Jul 2026	Purchase	19.37 Cr	₹168.72	11.48 L	Bulk	0.391057	NSE
08 Jul 2026	Purchase	26.91 Cr	₹170.97	15.74 L	Bulk	0.536278	NSE
08 Jul 2026	Purchase	26.16 Cr	₹168.77	15.50 L	Bulk	0.528044	NSE
08 Jul 2026	Sell	36.67 Cr	₹169.61	21.62 L	Bulk	0.736555	NSE
08 Jul 2026	Sell	25.83 Cr	₹170.49	15.15 L	Bulk	0.516173	NSE
07 Jul 2026	Purchase	73.65 Cr	₹166.65	44.19 L	Bulk	1.505556	NSE
09 Sep 2025	Sell	20.13 Cr	₹117.88	17.08 L	Bulk	0.581805	NSE
09 Sep 2025	Sell	24.36 Cr	₹117.47	20.74 L	Bulk	0.70649	NSE
09 Sep 2025	Purchase	63.49 Cr	₹117.96	53.83 L	Bulk	1.833774	NSE

Insider trading & SAST

Client name

Ncvi Enterprises Ltd & Pacs

Mayadevi Polycot Ltd & Pacs

Ncvi Enterprises Ltd & Pacs

Nm Merchantiles Ltd

Mayadevi Polycot Ltd & Pacs

Ncvi Enterprises Limited

Mayadevi Polycot Limited

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
17 Apr 2026	Promoter	Acquisition	0.24	56.86	0	—	7 L	16 Mar 2026	Market	16,69,04,180	SAST	29(2)	—
17 Apr 2026	Promoter	Acquisition	0.24	57.34	0	—	7 L	18 Mar 2026	Market	16,83,12,500	SAST	29(2)	—
17 Apr 2026	Promoter	Acquisition	0.22	57.08	0	—	6.54 L	17 Mar 2026	Market	16,75,58,303	SAST	29(2)	—
17 Apr 2026	Promoter	Acquisition	0.14	57.48	0	—	4.04 L	19 Mar 2026	Market	16,87,16,805	SAST	29(2)	—
17 Apr 2026	Promoter	Acquisition	4	17.08	0	—	1.17 Cr	05 Mar 2026	Merger	5,01,31,650	SAST	29(2)	—
17 Apr 2026	Promoter	Acquisition	0.02	57.1	0	—	54.20 K	18 Mar 2026	Market	16,76,12,500	SAST	29(2)	—
20 Mar 2026	Promoter Group	Acquisition	0.13774	16.58	3.01 Cr	₹74.56	4.04 L	19 Mar 2026	Market Purchase	4,86,55,000	Insider Trading	—	Equity Shares
19 Mar 2026	Promoter Group	Acquisition	0.238479	16.44	5.14 Cr	₹73.44	7 L	18 Mar 2026	Market Purchase	4,82,50,695	Insider Trading	—	Equity Shares
19 Mar 2026	Promoter Group	Acquisition	0.018464	21.78	40 L	₹73.81	54.20 K	18 Mar 2026	Market Purchase	6,39,45,330	Insider Trading	—	Equity Shares
18 Mar 2026	Promoter Group	Acquisition	0.222849	21.76	4.47 Cr	₹68.36	6.54 L	17 Mar 2026	Market Purchase	6,38,91,133	Insider Trading	—	Equity Shares